Poxvirus A46 protein binds to TIR domain-containing Mal/TIRAP via an α-helical sub-domain

Molecular Immunology

Volumn 48, Issue 15-16, 2011, Pages 2144-2150

  Oda, Shun ichiro ^a   Franklin, Edward ^a   Khan, Amir R ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Innate immune signaling; MyD88 adaptor like; Toll like interleukin 1 receptor (TIR) domain; Vaccinia virus protein A46; Viral immune evasion

Indexed keywords

MAL PROTEIN; MONOMER; POXVIRUS A46 PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; IN VITRO STUDY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; SURFACE PLASMON RESONANCE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; CIRCULAR DICHROISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, INTERLEUKIN-1; SPECTRUM ANALYSIS; SURFACE PLASMON RESONANCE; VACCINIA VIRUS; VIRAL PROTEINS;

DNA VIRUSES; POXVIRIDAE; VACCINIA VIRUS;

EID: 80051922422     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.07.014     Document Type: Article

References (32)

1. Bahar M.W., Graham S.C., Chen R.A., Cooray S., Smith G.L., Stuart D.I., Grimes J.M. How vaccinia virus has evolved to subvert the host immune response. J. Struct. Biol. 2011, 286. (Epub ahead of print).
2. Benfield C.T., Mansur D., McCoy L.E., Ferguson B.J., Bahar M., Oldring A.P., Grimes J.M., Stuart D.I., Graham S.C., Smith G.L. Mapping the i{kappa}B kinase beta (ikk{beta})-binding interface of B14, a vaccinia virus inhibitor of IKK{beta}-mediated activation of nuclear factor kappa B. J. Biol. Chem. 2011, 286:20727-20735.
3. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10162-10167.
4. Douglas A., Corbett K., Berger J., McFadden G., Handel T. Structure of M11L, a myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2. Protein Sci. 2007, 16:695-703.
5. Dunne A., Ejdeback M., Ludidi P.L., O'Neill L.A., Gay N.J. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88. J. Biol. Chem. 2003, 278:41443-41451.
6. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., Monks B., Pitha P.M., Golenbock D.T. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 2003, 198:1043-1055.
7. Gonzalez J.M., Esteban M. A poxvirus Bcl-2-like gene family involved in regulation of host immune response, sequence similarity and evolutionary history. Virol. J. 2010, 7:59.
8. Graham S.C., Bahar M.W., Cooray S., Chen R.A., Whalen D.M., Abrescia N.G., Alderton D., Owens R.J., Stuart D.I., Smith G.L., Grimes J.M. Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog. 2008, 4:e1000128.
9. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W., Smith G.L., Bowie A., O'Neill L.A. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 2003, 197:343-351.
10. Kabsch W., Sander C. Dictionary of protein secondary structure, pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983, 22:2577-2637.
11. Kalverda A.P., Thompson G.S., Vogel A., Schroder M., Bowie A.G., Khan A.R., Homans S.W. Poxvirus K7 protein adopts a Bcl-2 fold, biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J. Mol. Biol. 2009, 385:843-853.
12. Kvansakul M., van Delft M.F., Lee E.F., Gulbis J.M., Fairlie W.D., Huang D.C., Colman P.M. A structural viral mimic of prosurvival Bcl-2, a pivotal role for sequestering proapoptotic Bax and Bak. Mol. Cell 2007, 25:933-942.
13. Lees J.G., Miles A.J., Wien F., Wallace B.A. A reference database for circular dichroism spectroscopy covering fold and secondary structure space. Bioinformatics 2006, 13:1955-1962.
14. Lin S.C., Lo Y.C., Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010, 465:885-890.
15. Lysakova-Devine T., Keogh B., Harrington B., Nagpal K., Halle A., Golenbock D.T., Monie T., Bowie A.G. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J. Immunol. 2010, 185:4261-4271.
16. McCoy S.L., Kurtz S.E., Macarthur C.J., Trune D.R., Hefeneider S.H. Identification of a peptide derived from vaccinia virus A52R protein that inhibits cytokine secretion in response to TLR-dependent signaling and reduces in vivo bacterial-induced inflammation. J. Immunol. 2005, 174:3006-3014.
17. McGuffin L.J., Bryson K., Jones D.T. The PSIPRED protein structure prediction server. Bioinformatics 2000, 16:404-405.
18. Nunez Miguel R., Wong J., Westoll J.F., Brooks H.J., O'Neill L.A., Gay N.J., Bryant C.E., Monie T.P. A dimer of the Toll-like receptor 4 cyto-plasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS One 2007, 2. e788.
19. O'Neill L. Translational mini-review series on Toll-like receptors, recent advances in understanding the role of Toll-like receptors in anti-viral immunity. Curr. Opin. Immunol. 2006, 18:3-9.
20. O'Neill L.A., Bowie A.G. The family of five, TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
21. Oda S., Schroder M., Khan A.R. Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7. Structure 2009, 17:1528-1538.
22. Rost B., Yachdav G., Liu J. The PredictProtein server. Nucleic Acids Res. 2004, 32:W321-W326.
23. Schroder M., Baran M., Bowie A.G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 2008, 27:2147-2157.
24. Soulat D., Burckstummer T., Westermayer S., Goncalves A., Bauch A., Stefanovic A., Hantschel O., Bennett K.L., Decker T., Superti-Furga G. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 2008, 27:2135-2146.
25. Sreerama N., Woody R.W. Estimation of protein secondary structure from circular dichroism spectra, comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 2000, 287:252-260.
26. Stack J., Haga I.R., Schroder M., Bartlett N.W., Maloney G., Reading P.C., Fitzgerald K.A., Smith G.L., Bowie A.G. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 2005, 201:1007-1018.
27. Takaoka A., Taniguchi T. Cytosolic DNA recognition for triggering innate immune responses. Adv. Drug Deliv. Rev. 2008, 60:847-857.
28. Watters T., Kenny E., O'Neill L. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol. Cell Biol. 2007, 85:411-419.
29. Whitmore L., Wallace B.A. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 2004, 32:W668-W673.
30. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
31. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K., Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 2003, 4:1144-1150.
32. Zahringer U., Lindner B., Inamura S., Heine H., Alexander C. TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 2008, 213:205-224.